Results 121 to 130 of about 390,681 (199)

Temporal single-cell atlas of full-length Huntington's disease mouse model defines stage-specific signatures of corticostriatal dysfunction. [PDF]

Mol Neurodegener
Robbins AB, Ranum PT, Huerta-Ocampo I, Kuckyr M, Davidson BL.   +4 more
europepmc   +1 more source

Lower Muscarinic M₁ Receptor Availability in Schizophrenia: In Vivo Positron Emission Tomography Evidence. [PDF]

Biol Psychiatry
Volpi T, Radhakrishnan R, Hird R, Naganawa M, Nabulsi N, Najafzadeh S, Jacutin-Porte S, Labaree D, Carson RE, Huang Y, D'Souza DC.   +10 more
europepmc   +1 more source

M4-ipRGCs regulate contrast sensitivity in vision. [PDF]

Cell Rep
Daly KM, Li X, Rathore S, Komal R, Beier C, Ostermeyer GP, Leffler J, Alam NM, Prusky GT, Robinson PR, Sivyer B, Grimes WN, Diamond JS, Brown RL, Hattar S.   +14 more
europepmc   +1 more source

Relationships between primal emotional systems and the sense of loneliness: The mediating role of early maladaptive schemas. [PDF]

PLoS One
Talarowska-Dublicka M, Gapińska A, Finogenow M.   +2 more
europepmc   +1 more source

Targeting muscarinic receptors for treating schizophrenia. [PDF]

Neurotherapeutics
Paul SM, Yohn SE.
europepmc   +1 more source

The central cholinergic system as a therapeutic target in Parkinson's disease. [PDF]

J Parkinsons Dis
Miller SJ, Yue JS, Bozal SB, Logan R, Hafler BP.   +4 more
europepmc   +1 more source

Targeting disrupted networks in schizophrenia: Can muscarinic drugs make a fundamental difference? [PDF]

J Psychopharmacol
Pratt JA, Morris BJ.
europepmc   +1 more source

Anatomical and radiological analysis of ventricular catheter trajectories: neuronavigation-guided dissection and tractography-based 3D visualization. [PDF]

Neurosurg Rev
Kara CF, Akyüz ME, Elveren M, Temtek U, Zeynal M, Kapakin S, Yalçın A, Gök E, Kadıoğlu HH, Şahin MH.   +9 more
europepmc   +1 more source